or Try an Advanced Search...

    Technical Analysis for TCBP - TC BioPharm (Holdings) plc

    Grade Last Price % Change Price Change
    F 0.63 5.83% 0.03
    TCBP closed up 5.83 percent on Wednesday, November 20, 2024, on 49 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical TCBP trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 5.83%
    Boomer Sell Setup Bearish Swing Setup 5.83%
    NR7 Range Contraction 5.83%
    Narrow Range Bar Range Contraction 5.83%
    Inside Day Range Contraction 5.83%
    Wide Bands Range Expansion 5.83%
    Oversold Stochastic Weakness 5.83%
    Older End-of-Day Signals for TCBP ...

       Recent Intraday Alerts

    Alert Time
    Up 10% about 19 hours ago
    Rose Above Previous Day's High about 19 hours ago
    Up 5% about 19 hours ago
    60 Minute Opening Range Breakout about 20 hours ago
    Up 3% about 20 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TCBP Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Solid Tumors Immune System Immunotherapy Cancer Treatment Cancer Immunotherapy Cell Therapy Acute Myeloid Leukemia Cell Biology Treatment Of Acute Myeloid Leukemia T Cells Immunotherapy Products

    Is TCBP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant
    Oct 30 TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements
    Oct 28 Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
    Oct 25 TCBP Responds to False Social Media Claim
    Oct 22 TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic
    Oct 3 TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening
    Sep 25 TCBP Announces Site Opening of Guys and St. Thomas Hospital
    Sep 24 TCBP to Present at the 2024 ThinkEquity Conference in NYC
    Sep 20 /C O R R E C T I O N -- TC BioPharm/
    Sep 12 TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial
    See more TCBP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 138.0
    52 Week Low 0.5574
    Average Volume 1,358,404
    200-Day Moving Average 8.90
    50-Day Moving Average 3.76
    20-Day Moving Average 1.16
    10-Day Moving Average 0.86
    Average True Range 0.37
    RSI (14) 23.08
    ADX 44.34
    +DI 11.39
    -DI 36.81
    Chandelier Exit (Long, 3 ATRs) 2.78
    Chandelier Exit (Short, 3 ATRs) 1.65
    Upper Bollinger Bands 1.94
    Lower Bollinger Band 0.39
    Percent B (%b) 0.15
    BandWidth 132.78
    MACD Line -0.87
    MACD Signal Line -0.96
    MACD Histogram 0.0872
    Fundamentals Value
    Market Cap 426.2 Thousand
    Num Shares 677 Thousand
    EPS -71.42
    Price-to-Earnings (P/E) Ratio -0.01
    Price-to-Sales 0.36
    Price-to-Book 0.29
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.75
    Resistance 3 (R3) 0.75 0.70 0.73
    Resistance 2 (R2) 0.70 0.67 0.70 0.72
    Resistance 1 (R1) 0.67 0.65 0.68 0.67 0.72
    Pivot Point 0.62 0.62 0.63 0.62 0.62
    Support 1 (S1) 0.59 0.59 0.61 0.59 0.54
    Support 2 (S2) 0.54 0.57 0.55 0.54
    Support 3 (S3) 0.51 0.54 0.53
    Support 4 (S4) 0.51